BMO Capital Markets Lowers Ionis Pharmaceuticals (NASDAQ:IONS) Price Target to $45.00
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) had its price objective lowered by BMO Capital Markets from $60.00 to $45.00 in a report released on Thursday,Benzinga reports. The firm currently has a “market perform” rating on the stock. BMO Capital Markets’ target price would indicate a potential upside of 39.20% from the stock’s previous close. […]
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) had its price objective lowered by BMO Capital Markets from $60.00 to $45.00 in a report released on Thursday,Benzinga reports. The firm currently has a “market perform” rating on the stock. BMO Capital Markets’ target price would indicate a potential upside of 39.20% from the stock’s previous close. […]
